Eurofins, FR0014000MR3

Eurofins Scientific stock falls 2.79 percent to EUR 77.03

Published on 09/29/2026 at 16:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eurofins Scientific stock was at EUR 77.03 on September 29, 2026, after Bernstein cut its target to EUR 73.90. H1 adjusted EBITDA margin reached 23.70 percent.

Wissenschaftlerin analysiert Lebensmittelproben mit Pipette im modernen Testlabor
Fotorealistisches Labor mit Pipetten zeigt Eurofins Scientific SE, den Prüfdienstleister mit ISIN FR0014000MR3, bei Probenanalyse, Illustration mit AI erstellt.

Eurofins Scientific (ISIN FR0014000MR3) stock was trading at EUR 77.03 at Lang & Schwarz on September 29, 2026, at 4:39 p.m. CEST, down 2.79 percent versus the prior close of EUR 79.24. The immediate catalyst was a Bernstein downgrade reported by TradingView on September 29, 2026.

Bernstein shifts back to growth

Bernstein lowered its recommendation from outperform to market perform and cut the price target from EUR 77.20 to EUR 73.90. The target change gives the stock a clear near-term valuation checkpoint because the new target sits below the Lang & Schwarz price of EUR 77.03.

The research note said Eurofins' 2027 profitability objective appears achievable, but margin progress is no longer enough to offset concerns about weaker growth. It pointed to softer clinical and research-and-development activity in Europe and subdued biopharma expansion, according to TradingView.

Margins improve faster than revenue

Eurofins published its H1 2026 results on July 23, 2026, with adjusted EBITDA margin up 130 basis points to 23.70 percent and EPS growth of 29.00 percent. The company also reported 2.70 percent organic revenue growth for the period, according to the H1 earnings-call transcript carried by Yahoo Finance.

The contrast is central to the stock story. Profitability is moving ahead while top-line growth remains below Eurofins' long-term objective of 6.50 percent average annual growth. Management reaffirmed its objective of a 24.00 percent adjusted EBITDA margin for fiscal year 2027 on the investor-relations page dated July 23, 2026, which also lists investor events for October 23 and November 11, 2026, at Eurofins.

Stock remains below its yearly high

Eurofins had a market capitalization of EUR 13.3 billion on September 29, 2026. Its 52-week range was EUR 54.86 to EUR 79.22, placing the Lang & Schwarz price EUR 2.19 below the quoted yearly high.

Eurofins stock trades at EUR 77.03

Eurofins stock was trading at EUR 77.03 at Lang & Schwarz on September 29, 2026, at 4:39 p.m. CEST, down 2.79 percent versus the Lang & Schwarz prior close of EUR 79.24 on September 28, 2026. The company is listed on Euronext Paris and belongs to the CAC 40.

Eurofins Scientific stock at a glance

  • Company: Eurofins Scientific SE
  • ISIN: FR0014000MR3
  • Ticker: ERF
  • Primary exchange: Euronext Paris
  • Price Lang & Schwarz (as of September 29, 2026, 4:39 p.m. CEST): EUR 77.03
  • Change versus prior close: minus 2.79 percent
  • Prior close Lang & Schwarz (September 28, 2026): EUR 79.24
  • Market capitalization: EUR 13.3 billion (as of September 29, 2026)
  • 52-week range: EUR 54.86-EUR 79.22 (as of September 29, 2026)
  • Sector / Industry: Healthcare / Life Sciences Tools and Services
  • Index membership: CAC 40

More news and analyses on Eurofins Scientific stock

Disclaimer...

en | FR0014000MR3 | EUROFINS | boerse | 70199277 | bgmi